| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-99 |
Sentence |
denotes |
Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. |
| T1 |
0-99 |
Sentence |
denotes |
Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. |
| TextSentencer_T2 |
100-108 |
Sentence |
denotes |
PURPOSE: |
| T2 |
100-108 |
Sentence |
denotes |
PURPOSE: |
| TextSentencer_T3 |
109-255 |
Sentence |
denotes |
Detection of occult carcinoma in patients with breast cancer may aid the establishment of prognosis and development of new therapeutic approaches. |
| T3 |
109-255 |
Sentence |
denotes |
Detection of occult carcinoma in patients with breast cancer may aid the establishment of prognosis and development of new therapeutic approaches. |
| TextSentencer_T4 |
256-524 |
Sentence |
denotes |
To improve on existing methods of detection, we have developed a reverse-transcriptase polymerase chain reaction (RT-PCR) assay for keratin 19 (K19) transcripts to identify mammary carcinoma cells in the peripheral blood and bone marrow of patients with breast cancer. |
| T4 |
256-524 |
Sentence |
denotes |
To improve on existing methods of detection, we have developed a reverse-transcriptase polymerase chain reaction (RT-PCR) assay for keratin 19 (K19) transcripts to identify mammary carcinoma cells in the peripheral blood and bone marrow of patients with breast cancer. |
| TextSentencer_T5 |
525-546 |
Sentence |
denotes |
PATIENTS AND METHODS: |
| T5 |
525-546 |
Sentence |
denotes |
PATIENTS AND METHODS: |
| TextSentencer_T6 |
547-741 |
Sentence |
denotes |
Peripheral-blood or bone marrow samples obtained from 34 patients with stages I to IV breast cancer and 39 control subjects without breast cancer were screened for K19 mRNA by nested primer PCR. |
| T6 |
547-741 |
Sentence |
denotes |
Peripheral-blood or bone marrow samples obtained from 34 patients with stages I to IV breast cancer and 39 control subjects without breast cancer were screened for K19 mRNA by nested primer PCR. |
| TextSentencer_T7 |
742-750 |
Sentence |
denotes |
RESULTS: |
| T7 |
742-750 |
Sentence |
denotes |
RESULTS: |
| TextSentencer_T8 |
751-900 |
Sentence |
denotes |
In reconstitution experiments, K19 RT-PCR reliably detected 10 mammary carcinoma cells in 1 million normal peripheral-blood mononuclear (PBMN) cells. |
| T8 |
751-900 |
Sentence |
denotes |
In reconstitution experiments, K19 RT-PCR reliably detected 10 mammary carcinoma cells in 1 million normal peripheral-blood mononuclear (PBMN) cells. |
| TextSentencer_T9 |
901-999 |
Sentence |
denotes |
Four of 19 patients with stage IV breast cancer had detectable K19 transcript in peripheral blood. |
| T9 |
901-999 |
Sentence |
denotes |
Four of 19 patients with stage IV breast cancer had detectable K19 transcript in peripheral blood. |
| TextSentencer_T10 |
1000-1185 |
Sentence |
denotes |
Five of six patients with histologically negative bone marrow biopsies following preablative chemotherapy and before autologous bone marrow transplant (BMT) were positive by this assay. |
| T10 |
1000-1185 |
Sentence |
denotes |
Five of six patients with histologically negative bone marrow biopsies following preablative chemotherapy and before autologous bone marrow transplant (BMT) were positive by this assay. |
| TextSentencer_T11 |
1186-1326 |
Sentence |
denotes |
Stem-cell apheresis harvests obtained from one of these patients and three additional patients immediately before BMT were all K19-negative. |
| T11 |
1186-1326 |
Sentence |
denotes |
Stem-cell apheresis harvests obtained from one of these patients and three additional patients immediately before BMT were all K19-negative. |
| TextSentencer_T12 |
1327-1437 |
Sentence |
denotes |
K19 RT-PCR analysis of CSF from a breast cancer patient with known carcinomatous meningitis was also positive. |
| T12 |
1327-1437 |
Sentence |
denotes |
K19 RT-PCR analysis of CSF from a breast cancer patient with known carcinomatous meningitis was also positive. |
| TextSentencer_T13 |
1438-1515 |
Sentence |
denotes |
Thirty-eight of 39 non-breast cancer patients had negative K19 RT-PCR assays. |
| T13 |
1438-1515 |
Sentence |
denotes |
Thirty-eight of 39 non-breast cancer patients had negative K19 RT-PCR assays. |
| TextSentencer_T14 |
1516-1582 |
Sentence |
denotes |
The one exception was a patient with chronic myelogenous leukemia. |
| T14 |
1516-1582 |
Sentence |
denotes |
The one exception was a patient with chronic myelogenous leukemia. |
| TextSentencer_T15 |
1583-1771 |
Sentence |
denotes |
CONCLUSION: RT-PCR of K19 is a sensitive, specific, and rapid method for detection of occult mammary carcinoma cells in the peripheral blood and bone marrow of patients with breast cancer. |
| T15 |
1583-1771 |
Sentence |
denotes |
CONCLUSION: RT-PCR of K19 is a sensitive, specific, and rapid method for detection of occult mammary carcinoma cells in the peripheral blood and bone marrow of patients with breast cancer. |
| TextSentencer_T16 |
1772-1926 |
Sentence |
denotes |
The presence of residual breast cancer cells in histologically normal bone marrow aspirates but not in stem-cell apheresis harvests is a frequent finding. |
| T16 |
1772-1926 |
Sentence |
denotes |
The presence of residual breast cancer cells in histologically normal bone marrow aspirates but not in stem-cell apheresis harvests is a frequent finding. |
| TextSentencer_T17 |
1927-2049 |
Sentence |
denotes |
This assay may be useful in diagnosing metastatic disease, as well as in monitoring the effectiveness of systemic therapy. |
| T17 |
1927-2049 |
Sentence |
denotes |
This assay may be useful in diagnosing metastatic disease, as well as in monitoring the effectiveness of systemic therapy. |